Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. - Wikidata - awgldk - TriplyDB

Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

http://www.wikidata.org/entity/Q42870965

about

Tissue patterning and cellular mechanics Non-muscle myosin II in disease: mechanisms and therapeutic opportunities Early events in cell spreading as a model for quantitative analysis of biomechanical events Competition for actin between two distinct F-actin networks defines a bistable switch for cell polarization.Regulated lysosomal exocytosis mediates cancer progression Comprehensive mutation profiling of mucinous gastric carcinoma.CRISPR-Cas9: from Genome Editing to Cancer Research Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma CRISPR-Cas9 knockin mice for genome editing and cancer modeling Myosin light chain kinase regulates cell polarization independently of membrane tension or Rho kinase.SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.Life without double-headed non-muscle myosin II motor proteins.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis RNAi therapies: drugging the undruggable.Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis.CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma The role of vertebrate nonmuscle Myosin II in development and human disease.Pharmacological activation of myosin II paralogs to correct cell mechanics defects.Drugging the undruggable RAS: Mission possible?Emerging interactions between skin stem cells and their niches.A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1.Four things to know about myosin light chains as reporters for non-muscle myosin-2 dynamics in live cells.High-throughput functional genomics using CRISPR-Cas9.Myosin II isoform co-assembly and differential regulation in mammalian systems Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction.Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(∗) in SCC progression.Conditional deletion of nonmuscle myosin II-A in mouse tongue epithelium results in squamous cell carcinoma piggyBac mediates efficient in vivo CRISPR library screening for tumorigenesis in mice Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.Onco-Golgi: Is Fragmentation a Gate to Cancer Progression?Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes Nuclear lamins in cancer Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation.MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.Substrate Stiffness Influences Doxorubicin-Induced p53 Activation via ROCK2 Expression.RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system.

P2860

Q26778749-4950A5C8-00F6-42C2-9C7C-50B9AD7318EA Q26778962-8F0FEB0C-CB26-47FB-93FE-554F9CFAA10A Q26821973-53C30F57-423D-45F6-A517-AA698E9BB473 Q27312648-6DB32327-17B3-4D47-8167-AB54C7746B14 Q27339507-ADF9E006-9459-4E6E-9D80-56C467B3B111 Q27853392-01080681-B63C-42D6-92F8-94CA03F9D8AF Q28066263-59B7A015-37ED-4BC2-92DE-369CAB891417 Q28384371-1E1449FC-D889-4923-A6B4-510CB438A146 Q30607892-2DE0059B-9FE9-44CA-B0A6-A497BD3B09A3 Q30644151-3F30D52A-8BA1-45CF-8839-0A1EDD707DBC Q33576879-9E73A145-8FE6-46E3-A81D-6C8EB1887B31 Q33623668-3B8A4618-491F-4D78-8BFF-416F6C95D0E8 Q33852054-263C48E0-52C7-4001-AF44-15B114A7351E Q33907993-ECCA4010-208F-4210-A8CD-F2F67532BB5B Q34043392-37E4B221-54F5-40E8-8156-BE2CD07BE215 Q34131220-65C46A5A-03AB-427A-8853-C90C8A16ACF1 Q34207052-A305F4C3-9348-4329-8308-7DDE737287DA Q34342934-8E1831EA-C8C3-489E-9A13-7D992BDC6E9B Q34362453-8B7C29CA-ECFA-4E8A-9260-68E2981C58CD Q35062582-F6658DD4-6BC8-416A-B397-1267B23F5362 Q35163434-17B81FDE-6D69-4DCA-8E5C-7290A44975DC Q35174984-40DD98D7-80F4-4481-9DD3-A856D7547EAC Q35441295-2DAFEA2D-67A1-40EA-BF9A-F1C2F1574100 Q35449974-4EEF42B7-790B-43BC-BDF6-00CA56218E53 Q35597703-CEE5DC20-722C-49F1-AB88-FFF96E819595 Q35613068-530448AD-BAF8-475D-B395-C5D36106CB53 Q35651091-539C5B0A-37DA-4255-BEC7-3525A878380F Q35855855-960BB775-8576-40BB-99DC-4B003B000A46 Q36067924-FFF53E0E-E218-450C-B4BD-65E655C50B47 Q36243531-57EE4DDD-BA33-434F-9B52-9C27F8B3EC5B Q36331953-5CF45FBC-27BE-43FD-9FC0-CBC343C434DC Q36340056-E91E5CA9-5900-4FF4-B6B5-F9F531AE6532 Q36372323-C7447DCA-D287-4A66-9E7D-E70D29CBDEFA Q36776494-9809EB8B-CF46-4929-BF88-7E36D470744A Q37096363-85252CD6-19B5-4764-8FE4-CA6ABF15059F Q37207687-9B2F3F68-53D4-4990-90E6-04055F1B69ED Q37564758-6873537D-4787-44D2-AC2E-39B45A469622 Q37599009-D8AB5651-7148-4805-86A4-BDE4EA29894F Q37612047-807F6A63-D9E0-4CB0-8E22-20F892932253 Q38268543-42B84348-D926-4967-8E63-6CE6170B67A6

P2860

Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

http://www.wikidata.org/entity/Q42870965

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@en

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@nl

type

label

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@en

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@nl

prefLabel

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@en

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@nl

P1433

Q42870965-8E71762D-72FF-448C-8D44-7907024A4F8C

P1476

Q42870965-C0704C1A-52E5-410F-8ED0-473416601CD0

P2093

Q42870965-3739BDBE-02D0-494A-A614-3AD0F4A66B32

Q42870965-4183E7D6-8674-4345-8B1B-5BD86BEAE0DD

Q42870965-66561EEF-619B-4EDE-942A-80E931609741

Q42870965-6B7E3C5B-C7E4-413B-9C8C-014A7E40BCB9

Q42870965-7B3A4A44-0D24-463C-B60E-3D687A610D9A

Q42870965-D9C8697B-5690-4998-A721-84D8CE4A68DD

Q42870965-FA668E34-9F97-4C4A-B34F-1C57C25DCCAD

P2860

Q42870965-06689BFB-5555-4940-9E36-CD4C217A1F7F

Q42870965-094F74A4-9DB8-44BA-B535-69A841A81E17

Q42870965-1E8788E3-573D-4DDD-8A9D-2094D11C5BE9

Q42870965-221DB5EC-8595-4CD7-AE81-20BEB1CC68FC

Q42870965-22A0F1A0-EC34-443B-B033-0236D3B09F4E

Q42870965-24334D39-F52A-47F2-BAA1-484E5030DA49

Q42870965-2984A9F6-EFA0-43F5-AE05-AA084792E307

Q42870965-3C6AAF53-D235-4B56-B1BD-84E108E8F39A

Q42870965-45B81D97-16EC-4726-8B74-49CB43370C86

Q42870965-4CD77623-BCA9-41F0-9133-BA284957DF41

P304

Q42870965-494A6993-EA5C-4150-9634-0BCBB64472C7

P31

Q42870965-51B9A488-EEE8-4399-B6A5-6B466B634DFD

P356

Q42870965-B025FC45-AEA3-4361-B8A6-3230A27ADE06

P407

Q42870965-DF60EDFC-03EA-4505-A00B-C5A2A9B06F65

P433

Q42870965-F59A0AD0-900C-40E0-BF22-DE65BD74476F

P478

Q42870965-2AC01B9C-AA74-4C9C-8C3A-6EDDDA0C9721

P50

Q42870965-B71D26FC-1FCC-4692-968F-C853D3B5E36F

P577

Q42870965-A0908FC6-28BD-4FEA-B245-5F74E63AEE8F

P698

Q42870965-E674AA7D-2905-4B87-A75B-C61055D4C9B6

P932

Q42870965-8CA53EF0-710B-49DB-A583-37180C4E0EFF

P356

SCIENCE.1248627

P1433

P1476

Direct in vivo RNAi screen unv ...... r of squamous cell carcinomas.

@en

P2093

Ataman Sendoel

http://www.w3.org/2001/XMLSchema#string

Boris Reva

http://www.w3.org/2001/XMLSchema#string

Daniel Oristian

http://www.w3.org/2001/XMLSchema#string

Daniel Schramek

http://www.w3.org/2001/XMLSchema#string

Evan Heller

http://www.w3.org/2001/XMLSchema#string

Jeremy P Segal

http://www.w3.org/2001/XMLSchema#string

Slobodan Beronja

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

Integrated genomic analyses of ovarian carcinoma

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

The mutational landscape of head and neck squamous cell carcinoma

Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

P304

309-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1248627

http://www.w3.org/2001/XMLSchema#string

P407

P433

6168

http://www.w3.org/2001/XMLSchema#string

P478

343

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24436421

http://www.w3.org/2001/XMLSchema#string

P932

4159249

http://www.w3.org/2001/XMLSchema#string